Clinical Trial

A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 4, 2025 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-117 in healthy subjects.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-26.
Trial Details
NCT Number NCT07152873
Lead Sponsor Addpharma Inc.
Conditions Mixed Dyslipidemia
Enrollment 60 participants
Start Date 2025-12-01
Primary Completion 2026-02 (estimated)
Study Completion 2026-03 (estimated)
Updated on ClinicalTrials.gov 2025-12-04